Bionic Ear Market Research Report—Global Forecast till 2027

Global Bionic Ear Market: By Device Type (Cochlear Implant, Auditory Brainstem Implants, Bone-Anchored Hearing Aid), By End User (Research Institutes, Hearing Clinics, Hospitals), and Region (North America, Europe, Asia-Pacific, Rest of the World)—Forecast to 2027

ID: MRFR/HC/9163-HCR | August 2021 | Region: Global | 120 pages

Market Forecast


The global bionic ear market is expected to cross ~USD 26,980.20 million by 2027 at a CAGR of ~8.10% during the forecast period.  


Market Overview:


A bionic ear is an electronic device termed as a neural prosthesis which is designed for the people suffering from hearing disability. Itcan stimulate the hearing nerve and provide sound signals directly to the brain. The bionic ear constitutes a receiver-stimulator and an external sound processor; both are fit behind the ear. Additionally, the sound processor captures the external sound and then converts it to a digital code. This digital code gets transmitted to the receiver-stimulator fitted behind the ear. Furthermore, the receiver develops the electrical signals with the help of the received digital code and sends them to the electrode array, which is present in the cochlea. These devices can be used by both,the ones suffering from profound loss or total loss.The rising prevalence of hearing disorders is likely to lift the demand for the product. The increasing aging population will also create a larger patient pool of people living with hearing loss. For instance, it is estimated that as of March 2019, around 466 million people globally are having disabling hearing loss.The number is expected to reach 900 million by 2050.


COVID-19 Analysis:


COVID-19 negatively impacted the bionic ear market. The pandemic resulted in severallockdown measures and added to the challenges ofpatients with hearing disabilities.Many hospitals were restricted to non-elective procedures and surgeries and reallocated hospital resources like nursing staff and ICU beds to care for patients with the coronavirus. Furthermore, there are limitations associated with treatments anda decline in the production of implantable bionics, which further restricted the growth of the bionic ear market. 


Market Dynamics:


Drivers:



  • Growing prevalence of hearing disorders


The rising prevalence of hearing disorders and the increasing geriatric population are likely to create a larger patient pool with hearing loss. For instance, according to the WHO,more than 360 million people in the world have hearing loss disabilities. Hearing loss is one of the leading disorders globally. According to the Royal National Institute for Deaf People, the disorder increases with age, affecting 70% of people over 70 and 42% of people over 50. Moreover,the prolonged exposure to noise in recreational settings, increasing healthcare spending and the prelaunch of bionic ear devices are some other factors driving the marketsize.



  • Growing demand for minimally invasive surgical techniques to boost the market


The demand for minimally invasive surgical techniques is increasing significantly andcannotablly augment the global market. There has been significant growth in the adoption of such equipment due to technological advancements and the establishment of favorable insurance schemes



  • Increasing R&D spending to develop next-generation sound processors

  • Rising parental awareness and the availability of infrastructure for diagnosing hearing disorders in newborn children


Restraints:



  • Regulatory requirement


The stringent approval procedure associated with the bionic ear implants is projected to significantly hamper the market growth during the forecast period.



  • High medical & device cost


Opportunities:



  • Increase in R&D activities on bionic ear


There have been increased R&D activities on bionic ears worldwide.Bionics institutes are aiming at improving the performance of bionic ears and the function of hearing nerves.


Segment Overview:


By Device Type


Based on device type, the bionic ears market is segmented into cochlear implant, auditory brainstem implants, and bone-anchored hearing aid.The cochlear implant segment held a significant share of the market in 2020.Cochlear implantsare found to be effective than traditional devices. These devices enhance the sound quality and thus improve a person's ability to better understand a speech.It also helps regain the clear sound in a noisy environment and is even considered safe for children.



  • Cochlear Implant: These are the only medical interventions that can restore partial hearing to a deafened person via electric stimulation of the residual auditory nerve. It can be a suitable option for people who have severe hearing loss from innerear damage and the use of hearing aids no longer helps.

  • Auditory brainstem implants: It is a surgically implanted electronic device that gives some onea sense of soundwho is profoundly deaf owing to retrocochlear hearing impairment. An auditory brainstem implant is made up oftwo parts: an external element (the 'processor,'which is worn on the ear) and theinternal part that is surgically implanted. In addition,The sound around the processor is picked up by a microphone on the processor, which converts it from a sound wave to an electrical signal. The sound signal is subsequently sent to the hearing implant's internal portion by the processor. This consists of a receiver located just beneath the epidermis and an implant array located within the brainstem.

  • Bone-anchored hearing aid:It is a hearing aid that works on the principle of bone conduction. It is designed for people with conductive hearing loss, unilateral hearing loss, single-sided deafness, and mixed hearing losses who cannot wear 'in the ear' or 'behind the ear' hearing aids otherwise.


By End User


Based on end user, the bionic ear market is segmented into research institutes, hearing clinics, ad hospitals.Growing healthcare expenditure and increasing demand for bionic ears are anticipated to contribute to the market's growth. On February 20, 2019, the WHO released a new report on global health expenditure, according to which global spending on health increased in low- and middle-income countries by 6 percent and in high-income countries by 4 percent.



  • Research Institutes: Research institutes are defined as organizations that conduct several studies on several subjects. The studies on bionic ear have increased in the past few years. The rise in funding for research projects is contributing to the growth of research institutes. Rising funding for research projects has also led to the rise in research institutes, thereby boosting the growth of the segment.

  • Hearing Clinics: Hearing clinics are expected to grow significantly owing to the specialized treatment and advancement of the facilities.

  • Hospitals:The hospital segment dominated the market and held the largest market share in 2020. Hospitals provide better treatment and have skilled medical staff, which attracts more patients.


Regional Analysis


North America


Increase in public awareness & technological advancements is driving the North America bionic ear market


North America dominated the bionic ear market in 2020 and is expected to continue its stronghold for a few more years. This is due to the increased public awareness among people and improved diagnostic facilities, and technological advancements in bionic ears.


Rising patient adoption and recognition of the product's benefits drive the growth of the bionic ear market in the US. Moreover, the presence of leading service providers such as Cochlear, Unitron, Intelligent Hearing System, and Advanced Bionics in the region will stimulate industry growth in the years to come.


Europe


Advancements in healthcare infrastructure are fueling the Europe bionic ear market


Europe is expected to be the second-largest bionic ear market due to investments in healthcare, technological advancements, favorable government policies, and increased income of individuals.


Asia-Pacific


Advancement in healthcare infrastructure and large population is fueling the Asia-Pacific bionic ear market


Asia-Pacific is anticipated to be the fastest-growing over the assessment period due to rapidly improving healthcare infrastructure and a large population.


Competitive Landscape


Companies are concentrating their efforts on bionic ear R&D. For instance, Doppler Labs, a start-up, has developed a bionic ear that allows users to control and personalize their hearing experience. Moreover, the companies are concentrating their efforts on the development of waterproof devices and improving their quality. In addition, few companies are working on wirelessly rechargeable bionic ears. 3D printing technology is playing a major role in the development of bionic ears.


List of Key Companies Covered in this Report:



  • Advanced Bionics (US)

  • Sonova (Switzerland)

  • Cochlear (Australia)

  • MED-EL (Austria)

  • WS Audiology (Singapore)

  • Oticon (Denmark)

  • Hangzhou Nurotron (China)

  • Listent Medical (China)

  • Medtronic PLC (Ireland)

  • Edward Lifesciences Corporation (US)

  • Ekso Bionics (US)

  • Ossur (Iceland)

  • LifeNet Health (US)

  • William Demant Holdings (Denmark)

  • Terumo Corporation (Japan)


Recent Developments



  • In May 2021, Sonova acquired the Consumer Division from Sennheiser Electronic GmbH & Co. KG (Sennheiser)

  • In February 2021, Phonak launched Roger Focus II.This tiny ear-level receiver is a potential option for children with Unilateral Hearing Loss, Auditory Processing Disorder, and Autism Spectrum Disorder.

  • In March 2019, Sivantos Inc. (US) and Widex A/S (Denmark) merged to become WS Audiology. The merger will create excellent products and further accelerate innovation with creative, high-tech, and easy-to-use products and services, broadening the choice for hearing aid users.


Report Overview


The study covers the existing short-term and long-term market effects. It also helps decision-makers to draught short-term and long-term plans for businesses by region. The report covers major regions such as North America, Europe, Asia-Pacific, and the Rest of the World. The report analyzes market drivers, restraints, opportunities, challenges, Porter's Five Forces, value chain, and the impact of COVID on the market.


Scope of the Report & Segmentation


By Device Type



  • Cochlear Implant

  • Auditory Brainstem Implants

  • Bone-Anchored Hearing Aid


By End User



  • Research Institutes

  • Hearing Clinics

  • Hospitals



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: ~USD 26,980.20 Million
  CAGR   ~8.10%
  Base Year   2020
  Forecast Period   2021-2027
  Historical Data   2018-2019
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Device Type & By End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   • Advanced Bionics (US) • Sonova (Switzerland) • Cochlear (Australia) • MED-EL (Austria) • Sivantos/ WS Audiology (Singapore) • Oticon (Denmark) • Hangzhou Nurotron (China) • Listent Medical (China) • Medtronic PLC (Ireland) • Edward Lifesciences Corporation (US) • Ekso Bionics (US) • Ossur (Iceland) • LifeNet Health (US) • William Demant Holdings (Denmark) • Terumo Corporation (Japan)
  Key Market Opportunities   Increase in Research and development activities on bionic ear
  Key Market Drivers   • Growing prevalence of hearing disorders • Growing demand for minimally invasive surgical techniques to boost the market


TABLE OF CONTENTS

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Techniques

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Rivalry

5.2. Value Chain Analysis

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Impact on Supply Chain

5.3.3. Regional Impact

5.3.4. Opportunity and Threat Analysis

6. GLOBAL BIONIC EAR MARKET, BY DEVICE TYPE

6.1. Overview

6.2. Cochlear implant

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

6.3. Auditory Brainstem Implants

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

6.4Bone-anchored hearing aid

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

7. GLOBAL BIONIC EAR MARKET, BY END USER

7.1. Overview

7.2. Research Institutes

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

7.3. Hearing Clinics

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

7.4. Hospitals

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

8. GLOBAL BIONIC EAR MARKET BY REGION

8.1. Overview

8.2. North America

8.2.1. US

8.2.2. Canada

8.3. Europe

8.3.1. Germany

8.3.2. France

8.3.3. Italy

8.3.4. Spain

8.3.5. UK

8.3.6. Rest of Europe

8.4. Asia-Pacific

8.4.1. Japan

8.4.2. China

8.4.3. India

8.4.4. Australia

8.4.5. South Korea

8.4.6. Rest of Asia-Pacific

8.5. Rest of the World

8.5.1. Middle East

8.5.2. Africa

8.5.3. Latin America

9. COMPANY LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Bionic Ear Market

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Global Bionic Ear Market

9.7. Key developments and Growth Strategies

9.7.1. New Product Launch/Service Deployment

9.7.2. Merger &Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales & Operating Income, 2020

9.8.2. Major Players R&D Expenditure, 2020

10. COMPANY PROFILES

10.1. Advanced Bionics

10.1.1. Company Overview

10.1.2. Products Offered

10.1.3. Financial Overview

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. Sonova

10.2.1. Company Overview

10.2.2. Products Offered

10.2.3. Financial Overview

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. Cochlear

10.3.1. Company Overview

10.3.2. Products Offered

10.3.3. Financial Overview

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. MED-EL

10.4.1. Company Overview

10.4.2. Products Offered

10.4.3. Financial Overview

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. WS Audiology

10.5.1. Company Overview

10.5.2. Products Offered

10.5.3. Financial Overview

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. Oticon

10.6.1. Company Overview

10.6.2. Products Offered

10.6.3. Financial Overview

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Hangzhou Nurotron

10.7.1. Company Overview

10.7.2. Products Offered

10.7.3. Financial Overview

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. Listent Medical

10.8.1. Company Overview

10.8.2. Products Offered

10.8.3. Financial Overview

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Medtronic PLC

10.9.1. Company Overview

10.9.2. Products Offered

10.9.3. Financial Overview

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. Edward Lifesciences corporation

10.10.1. Company Overview

10.10.2. Products Offered

10.10.3. Financial Overview

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

10.11. Ekso Bionics

10.11.1. Company Overview

10.11.2. Products Offered

10.11.3. Financial Overview

10.11.4. Key Developments

10.11.5. SWOT Analysis

10.11.6. Key Strategies

10.12. Ossur

10.12.1. Company Overview

10.12.2. Products Offered

10.12.3. Financial Overview

10.12.4. Key Developments

10.12.5. SWOT Analysis

10.12.6. Key Strategies

10.13. LifeNet Health

10.13.1. Company Overview

10.13.2. Products Offered

10.13.3. Financial Overview

10.13.4. Key Developments

10.13.5. SWOT Analysis

10.13.6. Key Strategies

10.14. William Demant Holdings

10.14.1. Company Overview

10.14.2. Products Offered

10.14.3. Financial Overview

10.14.4. Key Developments

10.14.5. SWOT Analysis

10.14.6. Key Strategies

10.15. Terumo Corporation

10.15.1. Company Overview

10.15.2. Products Offered

10.15.3. Financial Overview

10.15.4. Key Developments

10.15.5. SWOT Analysis

10.15.6. Key Strategies

11. APPENDIX

11.1. References

11.2. Related Reports


LIST OF TABLES

TABLE 1 GLOBAL BIONIC EAR MARKET SYNOPSIS, 2018–2027

TABLE 2 GLOBAL BIONIC EAR MARKET ESTIMATES &FORECAST, 2018–2027(USD MILLION)

TABLE 3 GLOBAL BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 4 GLOBAL BIONIC EAR MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 5 NORTH AMERICA: BIONIC EAR MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 6 NORTH AMERICA: BIONIC EAR MARKET, BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 7 NORTH AMERICA: BIONIC EAR MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 8 US: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 9 US: BIONIC EAR MARKET BY END USER, 2018–2027 (USD MILLION)

TABLE 10 CANADA: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 11 CANADA: BIONIC EAR MARKET BY END USER, 2018–2027 (USD MILLION)

TABLE 12 EUROPE: BIONIC EAR MARKET BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 13 EUROPE: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 14 EUROPE: BIONIC EAR MARKET BY END USER, 2018–2027 (USD MILLION)

TABLE 15 GERMANY: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 16 GERMANY: BIONIC EAR MARKET BY END USER, 2018–2027 (USD MILLION)

TABLE 17 FRANCE: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 18 FRANCE: BIONIC EAR MARKET BY END USER, 2018–2027 (USD MILLION)

TABLE 19 ITALY: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 20 ITALY: BIONIC EAR MARKET BY END USER, 2018–2027 (USD MILLION)

TABLE 21 SPAIN: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 22 SPAIN: BIONIC EAR MARKET BY END USER, 2018–2027 (USD MILLION)

TABLE 23 UK: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 24 UK: BIONIC EAR MARKET BY END USER, 2018–2027 (USD MILLION)

TABLE 25 REST OF EUROPE: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 26 REST OF EUROPE: BIONIC EAR MARKET BY END USER, 2018–2027 (USD MILLION)

TABLE 27 ASIA-PACIFIC: BIONIC EAR MARKET BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC: BIONIC EAR MARKET BY END USER, 2018–2027 (USD MILLION)

TABLE 30 JAPAN: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 31 JAPAN: BIONIC EAR MARKET BY END USER, 2018–2027 (USD MILLION)

TABLE 32 CHINA: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 33 CHINA: BIONIC EAR MARKET BY END USER, 2018–2027 (USD MILLION)

TABLE 34 INDIA: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 35 INDIA: BIONIC EAR MARKET BY END USER, 2018–2027 (USD MILLION)

TABLE 36 AUSTRALIA: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 37 AUSTRALIA: BIONIC EAR MARKET BY END USER, 2018–2027 (USD MILLION)

TABLE 38 SOUTH KOREA: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 39 SOUTH KOREA: BIONIC EAR MARKET BY END USER, 2018–2027 (USD MILLION)

TABLE 40 REST OF ASIA-PACIFIC: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 41 REST OF ASIA-PACIFIC: BIONIC EAR MARKET BY END USER, 2018–2027 (USD MILLION)

TABLE 42 REST OF THE WORLD: BIONIC EAR MARKET BY REGION, 2018–2027 (USD MILLION)

TABLE 43 REST OF THE WORLD: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 44 REST OF THE WORLD: BIONIC EAR MARKET BY END USER, 2018–2027 (USD MILLION)

TABLE 45 MIDDLE EAST: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 46 MIDDLE EAST: BIONIC EAR MARKET END USER, 2018–2027 (USD MILLION)

TABLE 47 AFRICA: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 48 AFRICA: BIONIC EAR MARKET END USER, 2018–2027 (USD MILLION)

TABLE 49 LATIN AMERICA: BIONIC EAR MARKET BY DEVICE TYPE, 2018–2027 (USD MILLION)

TABLE 50 LATIN AMERICA: BIONIC EAR MARKET END USER, 2018–2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BIONIC EAR MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BIONIC EAR MARKET

FIGURE 4 GLOBAL BIONIC EAR MARKET SHARE, BY DEVICE TYPE, 2020 (%)

FIGURE 5 GLOBAL BIONIC EAR MARKET SHARE, BY END USER, 2020 (%)

FIGURE 6 GLOBAL BIONIC EAR MARKET SHARE, BY REGION, 2020 (%)

FIGURE 7 NORTH AMERICAS: BIONIC EAR MARKET SHARE, BY REGION, 2020 (%)

FIGURE 8 EUROPE: BIONIC EAR MARKET SHARE, BY REGION, 2020 (%)

FIGURE 9 ASIA-PACIFIC: BIONIC EAR MARKET SHARE, BY REGION, 2020 (%)

FIGURE 10 REST OF THE WORLD: BIONIC EAR MARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 GLOBAL BIONIC EAR MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 12 ADVANCED BIONICS KEY FINANCIALS

FIGURE 13 ADVANCED BIONICS SWOT ANALYSIS

FIGURE 14 SONOVAKEY FINANCIALS

FIGURE 15 SONOVASWOT ANALYSIS

FIGURE 16 COCHLEARKEY FINANCIALS

FIGURE 17 COCHLEAR SWOT ANALYSIS

FIGURE 18 MED-EL KEY FINANCIALS

FIGURE 19 MED-ELSWOT ANALYSIS

FIGURE 20 WS AUDIOLOGY KEY FINANCIALS

FIGURE 21 WS AUDIOLOGY SWOT ANALYSIS

FIGURE 22 OTICON KEY FINANCIALS

FIGURE 23 OTICON SWOT ANALYSIS

FIGURE 24 HANGZHOU NUROTRON KEY FINANCIALS

FIGURE 25 HANGZHOU NUROTRON SWOT ANALYSIS

FIGURE 26 LISTENT MEDICAL KEY FINANCIALS

FIGURE 27 LISTENT MEDICAL SWOT ANALYSIS

FIGURE 28 MEDTRONIC PLC KEY FINANCIALS

FIGURE 29 MEDTRONIC PLC SWOT ANALYSIS

FIGURE 30 EDWARD LIFESCIENCES CORPORATION KEY FINANCIALS

FIGURE 31 EDWARD LIFESCIENCES CORPORATION SWOT ANALYSIS

FIGURE 32 EKSO BIONICS KEY FINANCIALS

FIGURE 33 EKSO BIONICS SWOT ANALYSIS

FIGURE 34 OSSUR KEY FINANCIALS

FIGURE 35 OSSUR SWOT ANALYSIS

FIGURE 36 LIFENET HEALTH KEY FINANCIALS

FIGURE 37 LIFENET HEALTH SWOT ANALYSIS

FIGURE 38 WILLIAM DEMANT HOLDINGS KEY FINANCIALS

FIGURE 39 WILLIAM DEMANT HOLDINGS SWOT ANALYSIS

FIGURE 40 TERUMO CORPORATION KEY FINANCIALS

FIGURE 41 TERUMO CORPORATION SWOT ANALYSIS



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.